-
Something wrong with this record ?
Role of HSF1 in cell division, tumorigenesis and therapy: a literature review
O. Fiser, P. Muller
Status not-indexed Language English Country England, Great Britain
Document type Journal Article, Review
Grant support
22-17102S
Grantová Agentura České Republiky
MH CZ - DRO MMCI, 00209805
Ministerstvo Zdravotnictví Ceské Republiky
project SALVAGE, P JAC; CZ.02.01.01/00/22_008/0 004 644
Ministerstvo Školství, Mládeže a Tělovýchovy
NLK
BioMedCentral
from 2006-01-12
BioMedCentral Open Access
from 2006
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
Springer Nature OA/Free Journals
from 2006-12-01
- Publication type
- Journal Article MeSH
- Review MeSH
Heat shock factor 1 (HSF1) is the master orchestrator of the heat shock response (HSR), a critical process for maintaining cellular health and protein homeostasis. These effects are achieved through rapid expression of molecular chaperones, the heat shock proteins (HSPs), which ensure correct protein folding, repair, degradation and stabilization of multiprotein complexes. In addition to its role in the HSR, HSF1 influences the cell cycle, including processes such as S phase progression and regulation of the p53 pathway, highlighting its importance in cellular protein synthesis and division. While HSF1 activity offers neuroprotective benefits in neurodegenerative diseases, its proteome-stabilizing function may also reinforce tumorigenic transformation. HSF1 overexpression in many types of cancer reportedly enhances cell growth enables survival, alters metabolism, weakens immune response and promotes angiogenesis or epithelial-mesenchymal transition (EMT) as these cells enter a form of "HSF1 addiction". Furthermore, the client proteins of HSF1-regulated chaperones, particularly Hsp90, include numerous key players in classical tumorigenic pathways. HSF1 thus presents a promising therapeutic target for cancer treatment, potentially in combination with HSP inhibitors to alleviate typical initiation of HSR upon their use.
Department of Experimental Biology Faculty of Science Masaryk University Brno Czech Republic
Research Centre for Applied Molecular Oncology Masaryk Memorial Cancer Institute Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25014483
- 003
- CZ-PrNML
- 005
- 20250905141321.0
- 007
- ta
- 008
- 250701s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13008-025-00153-1 $2 doi
- 035 __
- $a (PubMed)40287736
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Fiser, Otakar $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 245 10
- $a Role of HSF1 in cell division, tumorigenesis and therapy: a literature review / $c O. Fiser, P. Muller
- 520 9_
- $a Heat shock factor 1 (HSF1) is the master orchestrator of the heat shock response (HSR), a critical process for maintaining cellular health and protein homeostasis. These effects are achieved through rapid expression of molecular chaperones, the heat shock proteins (HSPs), which ensure correct protein folding, repair, degradation and stabilization of multiprotein complexes. In addition to its role in the HSR, HSF1 influences the cell cycle, including processes such as S phase progression and regulation of the p53 pathway, highlighting its importance in cellular protein synthesis and division. While HSF1 activity offers neuroprotective benefits in neurodegenerative diseases, its proteome-stabilizing function may also reinforce tumorigenic transformation. HSF1 overexpression in many types of cancer reportedly enhances cell growth enables survival, alters metabolism, weakens immune response and promotes angiogenesis or epithelial-mesenchymal transition (EMT) as these cells enter a form of "HSF1 addiction". Furthermore, the client proteins of HSF1-regulated chaperones, particularly Hsp90, include numerous key players in classical tumorigenic pathways. HSF1 thus presents a promising therapeutic target for cancer treatment, potentially in combination with HSP inhibitors to alleviate typical initiation of HSR upon their use.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Muller, Petr $u Research Centre for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Brno, Czech Republic. muller@mou.cz
- 773 0_
- $w MED00173234 $t Cell division $x 1747-1028 $g Roč. 20, č. 1 (2025), s. 11
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40287736 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250701 $b ABA008
- 991 __
- $a 20250905141309 $b ABA008
- 999 __
- $a ok $b bmc $g 2388098 $s 1251603
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 20 $c 1 $d 11 $e 20250426 $i 1747-1028 $m Cell division $n Cell Div $x MED00173234
- GRA __
- $a 22-17102S $p Grantová Agentura České Republiky
- GRA __
- $a MH CZ - DRO MMCI, 00209805 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a project SALVAGE, P JAC; CZ.02.01.01/00/22_008/0 004 644 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- LZP __
- $a Pubmed-20250701